News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
TRANSGENE Net Cash Expenditures and Cash Position as of March 31, 2007
April 16, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STRASBOURG, France, April 16 /PRNewswire-FirstCall/ -- Transgene S.A. (Eurolist Paris: FR0005175080) announces its cash position and net cash expenditures for the three months ending March 31, 2007 (unaudited figures, IAS/IFRS).
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Business
BioSpace
40 Under 40 winners make their mark on biopharma
October 6, 2026
·
3 min read
·
Angela Gabriel
Layoffs
2 Massachusetts biotechs call it quits
October 5, 2026
·
2 min read
·
Angela Gabriel
Licensing
Lilly doubles down on Gate alliance to unlock new drug class with another $870M+ in biobucks
October 5, 2026
·
2 min read
·
Heather McKenzie
Deals
Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset
October 5, 2026
·
2 min read
·
Gabrielle Masson